Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iridium Biosciences is a Massachusetts-based consultancy founded in 2009 that provides strategic and technical support to biotechnology innovators. Its team includes experts in process development for protein therapeutics, assay development for diagnostics and biomarkers, clinical/regulatory affairs, DNA platform technologies, and environmental health & safety. The firm supports projects ranging from proof-of-concept studies at startups to technology expansion at midsize biotechs and new opportunity exploration at large pharma companies. It does not develop its own drugs or diagnostics but instead offers individualized strategies tailored to client needs across the biotech/pharma spectrum.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iridium.